SEC Form 4 · accession 0001235802-15-000037

UROPLASTY INC · UPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 31, 2015

Accepted (ET)

Apr 2, 2015 · 4:25 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000890846

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 31, 2015	D	43,625	—	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (right to buy)^F2	$4.16	Mar 31, 2015	D	6,175	D	—	Sep 13, 2017	Common Stock	6,175	D
Stock Option (right to buy)^F3	$4.83	Mar 31, 2015	D	5,475	D	—	Sep 13, 2018	Common Stock	5,475	D
Stock Option (right to buy)^F4	$3.76	Mar 31, 2015	D	7,025	D	—	Sep 12, 2019	Common Stock	7,025	D
Stock Option (right to buy)^F5	$3.46	Mar 31, 2015	D	8,625	D	—	Sep 11, 2020	Common Stock	8,625	D

F1Disposed of pursuant to merger agreement between issuer and Cogentix Medical, Inc., formerly Vision-Sciences, Inc. ("Cogentix"), in exchange for 31,698 shares of Cogentix common stock on the effective date of the merger.
F2This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 4,486 shares of Cogentix stock for $5.73 per share.
F3This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 3,978 shares of Cogentix stock for $6.65 per share.
F4This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 5,104 shares of Cogentix stock for $5.18 per share.
F5This option is fully vested, was assumed by Cogentix in the merger and replaced with an option to purchase 6,267 shares of Cogentix stock for $4.77 per share.